Pharmacology & ToxicologybioRxivPreprint
Orally administered niclosamide-based organic/inorganic hybrid suppresses SARS-CoV-2 infection
G.-w. Jin, G. Choi, S. R. N…·J.-H. Choy
This paper develops an orally administered niclosamide-based hybrid compound that suppresses SARS-CoV-2 infection in a Syrian hamster model, reducing inflammation and lung injury.
DOI 10.1101/2022.07.19.500639